Monthly Archives: August 2021

A boomerang drug

On June 7, the U.S. Food and Drug Administration (FDA) approved a new treatment for Alzheimer’s Disease (AD), its first in nearly two decades. Manufactured by Biogen (a biotech company based in Cambridge, MA) and called Aduhelm, the drug was … Continue reading

Posted in Global Innovation, Health Care | Tagged , , , , , , | Leave a comment